Amplifon S.p.A Receivables 2019-2024 | AMFPF
Amplifon S.p.A receivables from 2019 to 2024. Receivables can be defined as the total amount of collectibles for a company
- Amplifon S.p.A receivables for the quarter ending September 30, 2024 were $0.394B, a 51.98% increase year-over-year.
- Amplifon S.p.A receivables for 2024 were $0.362B, a 0.85% increase from 2023.
- Amplifon S.p.A receivables for 2023 were $0.359B, a 28.63% increase from 2022.
- Amplifon S.p.A receivables for 2022 were $0.279B, a 9.43% decline from 2021.
| Amplifon S.p.A Annual Receivables (Millions of US $) |
|
|---|---|
| 2024 | $362 |
| 2023 | $359 |
| 2022 | $279 |
| 2021 | $308 |
| 2020 | $256 |
| 2019 | $310 |
| 2018 | $289 |
| Amplifon S.p.A Quarterly Receivables (Millions of US $) |
|
|---|---|
| 2024-03-31 | $394 |
| 2023-03-31 | $301 |
| 2022-03-31 | $298 |
| 2021-03-31 | $287 |
| 2020-03-31 | $259 |
| 2019-03-31 | $282 |
| 2018-12-31 | $289 |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $5.378B | $2.607B |
| Amplifon SpA provides hearing solutions and services. It operates principally in Italy, France, Spain, Portugal, Switzerland, Austria, Holland, the United States, Hungary and Egypt. Amplifon SpA is based in Milan, Italy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $147.077B | 27.58 |
| CVS Health (CVS) | United States | $83.011B | 10.32 |
| Elevance Health (ELV) | United States | $78.142B | 10.08 |
| Cencora (COR) | United States | $57.628B | 20.05 |
| DiDi Global (DIDIY) | China | $23.768B | 25.25 |
| Natera (NTRA) | United States | $22.306B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.229B | 17.22 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.751B | 0.00 |
| Solventum (SOLV) | United States | $13.128B | 13.90 |
| CochLear (CHEOY) | Australia | $12.788B | 0.00 |
| ICON (ICLR) | Ireland | $12.281B | 11.42 |
| Revvity (RVTY) | United States | $12.070B | 20.77 |
| Viatris (VTRS) | United States | $10.857B | 3.73 |
| Medpace Holdings (MEDP) | United States | $9.434B | 25.06 |
| Avantor (AVTR) | United States | $9.336B | 13.56 |
| Sonic Healthcare (SKHHY) | Australia | $8.582B | 0.00 |
| HealthEquity (HQY) | United States | $8.405B | 36.81 |
| Charles River Laboratories (CRL) | United States | $8.038B | 15.75 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.772B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $5.024B | 29.58 |
| BrightSpring Health Services (BTSG) | United States | $3.667B | 33.65 |
| Sotera Health (SHC) | United States | $3.375B | 19.18 |
| Surgery Partners (SGRY) | United States | $2.855B | 37.12 |
| Alignment Healthcare (ALHC) | United States | $2.647B | 0.00 |
| Concentras Parent (CON) | United States | $2.621B | 15.15 |
| Organon (OGN) | United States | $2.605B | 2.77 |
| GeneDx Holdings (WGS) | United States | $2.480B | 95.51 |
| Ardent Health (ARDT) | United States | $2.041B | 8.70 |
| Progyny (PGNY) | United States | $2.024B | 44.55 |
| PACS (PACS) | United States | $1.949B | 0.00 |
| Premier (PINC) | United States | $1.767B | 13.41 |
| GoodRx Holdings (GDRX) | United States | $1.750B | 35.00 |
| Teladoc Health (TDOC) | United States | $1.546B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.329B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.160B | 8.82 |
| CareDx (CDNA) | United States | $1.149B | 17.94 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.956B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.846B | 7.92 |
| QDM (QDMI) | Hong Kong, SAR China | $0.846B | 290.00 |
| Nutex Health (NUTX) | United States | $0.653B | 9.89 |
| Embecta (EMBC) | United States | $0.627B | 4.22 |
| InnovAge Holding (INNV) | United States | $0.567B | 0.00 |
| SBC Medicals (SBC) | United States | $0.552B | 0.00 |
| LifeMD (LFMD) | United States | $0.544B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.486B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.471B | 10.60 |
| Omada Health (OMDA) | $0.461B | 0.00 | |
| So-Young (SY) | China | $0.389B | 0.00 |
| Enhabit (EHAB) | United States | $0.375B | 30.88 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.348B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.338B | 0.00 |
| Beauty Health (SKIN) | United States | $0.257B | 0.00 |
| Oncology Institute (TOI) | United States | $0.256B | 0.00 |
| DocGo (DCGO) | United States | $0.153B | 25.00 |
| Pheton Holdings (PTHL) | China | $0.134B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.104B | 0.00 |
| KindlyMD (NAKA) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.079B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.055B | 0.00 |
| ModivCare (MODV) | United States | $0.054B | 0.00 |
| Biodesix (BDSX) | United States | $0.045B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.023B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |